# Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)

Clinical trial · Population Health Research Institute

- Archive id: nct:NCT05580666
- Published: 2022-10-14
- Venue: ClinicalTrials.gov
- ClinicalTrials.gov: https://clinicaltrials.gov/study/NCT05580666
- Source URL: https://clinicaltrials.gov/study/NCT05580666
- Provenance: clinicaltrials

## Abstract

A double blinded, placebo-controlled, multicenter trial to evaluate effectiveness of azithromycin prophylaxis on mortality in advanced HIV.

_Abstract reproduced under ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters._

## Trial details

- acronym: REVIVE
- status: RECRUITING
- phase: PHASE3
- study type: INTERVENTIONAL
- enrollment: 8000
- sponsor: Population Health Research Institute
- conditions: HIV Disease Progression
- interventions: DRUG: Azithromycin Oral Tablet; DRUG: Placebo oral tablet
- start date: 2023-05-08
- start date type: ACTUAL
- primary completion date: 2028-11-30
- has results: false
- data source: ClinicalTrials.gov
- data processed: 2026-10-29T09:00:05
- modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Topics: [Infectious Disease, Vaccines & Antimicrobial Resistance](https://space-kitty.com/topics/infectious-disease-amr)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.